Chinese Journal of Cancer Research

, Volume 13, Issue 3, pp 176–178 | Cite as

Study of the deletion mutation of glutathione transferase M1 gene and its role in susceptibility to hepatocellular carcinoma

  • Ma Yun 
  • Deng Zhuo-lin 
  • Wei Yi-ping 
Basic Investigation


Objection: To investigate the glutathione S transferase Ml (GSTM1) gene inherent deletion and its relation to prevalence of hepatocellular carcinoma (HCC) in Guangxi, China. Methods: The GSTM1 gene polymorphism of 120 HCC patients and 100 healthy subjects both from the same high aflatoxin B1 (AFB1) contaminated area were detected using PCR technique with special primers. Another 40 patients from AFB1 low risk area were also tested. Results: In HCC high risk area, it was found that the frequencies of GSTM1 null genotype in HCC patients and healthy subjects were 59% and 51% respectively, with no significant difference. However, the frequency of GSTMl-null genotype in control group from AFB1 low risk area was lower than those from high risk area (P<0.01). Conclusion: Populations in this HCC endemic region show a higher rate of GSTMl-null genotype, which may be partially responsible for the susceptibility to AFB1 induced HCC. But the detoxification effect of GSTM1 alone is not sufficient to resist the genetic toxicity of AFB1, especially in those people who expose to excess AFB1. The GSTM1 gene deletion would not be suitable as an independent predictor of susceptibility to HCC.

Key words

Hepatocellular carcinoma Aflatoxin B1 Glutathione S transferase M1 

CLC number



Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. [1]
    Guengerich FP, Shimada T, Raney KD, et al. Elucidation of catalytic specificities of human cytochrome P450 and glutathione S-transferase enzymes and relevance to molecular epidemiology [J]. Envir Health Perspectives 1992; 98:75.CrossRefGoogle Scholar
  2. [2]
    Salagoric J, Kalina I, Stubna J, et al. Genetic polymorphism of glutathione S-transferases Ml and Tl as a risk factor in lung and bladder cancers [J]. Neoplasma 1998; 45:312.Google Scholar
  3. [3]
    Comstock KE, Sanderson BJ.S, Claflin SG, et al. GST1 gene deletion determined by polymerase chain reaction [J]. Nucleic Acids Research 1990; 18:3670.PubMedCrossRefGoogle Scholar
  4. [4]
    Ma Yun, Deng Zhuolin, Le Chenyi, et al. The comparative study on mutational hot spot of p53 gene in hepatocellular carcinoma from AFB1 high and low risk area in Guangxi [J]. J Clin Exp Pthol 1997; 13:302.Google Scholar
  5. [5]
    McGlyNN KA, Rosvold EA, Lustbader ED, et al. Susceptibility to hepatocellular carcinoma is associated with genetic variation in the enzymatic detoxification of aflatoxin B1 [J]. Proc Natl Acad Sci USA 1995; 92:2384.PubMedCrossRefGoogle Scholar
  6. [6]
    Chen CJ, Yu MW, Liaw YF. Epidemiological characteristics and factors of hepatocellular carcinoma [J]. J Gastroenterol Hepatol 1997; 12:294.CrossRefGoogle Scholar
  7. [7]
    Hu Ying, Shen Fumin. Association between GSTM1 gene polymorphism of primary hepatocellular carcinoma and mutation of p53 codon 249 [J]. Chin J Med Genet 1997; 14:76.Google Scholar
  8. [8]
    Hsieh LL, Huang RC, Yu MW, et al. L-myc, GSTM1 genetic polymorphism and hepatocellular carcinoma risk among hepatitis B carriers [J]. Cancer Lett 1996; 103:171.PubMedCrossRefGoogle Scholar
  9. [9]
    Dong Chuanhui, Zi Xiaolin, Yu Shunzhang, et al. Relationship between deletion of glutathione S-transferase gene and susceptibility to primary hepatocellular carcinoma [J]. Chin J Public Health 1997; 16:141.Google Scholar
  10. [10]
    Chomarat P, Rice JM, Slagle BL, et al. Hepatitis B virus induced liver injury and altered expression of carcinogen metabolising enzymes: the role of the HBx protein [J]. Toxicol Lett 1998; 28:595.CrossRefGoogle Scholar

Copyright information

© Chinese Journal of Cancer Research 2001

Authors and Affiliations

  1. 1.Department of PathologyGuangxi Medical UniversityNanning

Personalised recommendations